These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7299238)

  • 1. Effect of inhibition of platelet function with carbenicillin or aspirin on experimental canine sudden death.
    Johnson GJ; Heckel R; Leis LA; Franciosa J
    J Lab Clin Med; 1981 Nov; 98(5):660-72. PubMed ID: 7299238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs.
    Johnson GJ; Rao GH; White JG
    Am J Pathol; 1978 Apr; 91(1):85-106. PubMed ID: 645824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
    J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation secondary to coronary obstruction.
    Moore S
    Circulation; 1976 Mar; 53(3 Suppl):I66-9. PubMed ID: 767018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet inhibition by increased tirofiban dosing during primary coronary angioplasty for ST elevation myocardial infarction.
    Kralisz P; Dobrzycki S; Nowak K; Kochman W; Gajewska-Bachórzewska H; Gugała K; Mezyński G; Prokopczuk P; Zuk J; Korecki J; Poniatowski B; Musiał W
    Kardiol Pol; 2004 May; 60(5):459-67. PubMed ID: 15247961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis in acute myocardial infarction and sudden death.
    Davies MJ
    Cardiovasc Clin; 1987; 18(1):151-9. PubMed ID: 3300980
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin does not prevent the attenuation of myocardial stunning by the ACE inhibitor ramiprilat.
    Rose J; Ehring T; Sakka SG; Skyschally A; Heusch G
    J Mol Cell Cardiol; 1996 Mar; 28(3):603-13. PubMed ID: 9011643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of complete or partial occlusion of a coronary artery.
    Moore S; Belbeck LW; Evans G; Pineau S
    Lab Invest; 1981 Feb; 44(2):151-7. PubMed ID: 7464040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.
    Lyman BT; Johnson GJ; White JG
    Am J Pathol; 1978 Aug; 92(2):473-90. PubMed ID: 677271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and prostaglandins in sudden death: therapeutic implications.
    Gelman JS; Mehta J
    Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet production in myocardial infarction and sudden cardiac death.
    Trowbridge EA; Slater DN; Kishk YT; Woodcock BW; Martin JF
    Thromb Haemost; 1984 Oct; 52(2):167-71. PubMed ID: 6523435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    Roux SP; Tschopp TB; Kuhn H; Steiner B; Hadváry P
    J Pharmacol Exp Ther; 1993 Jan; 264(1):501-8. PubMed ID: 8423548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets and ischemic heart disease.
    Weiss HJ
    N Engl J Med; 1980 Jan; 302(4):225-6. PubMed ID: 7350464
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes.
    Ivandic BT; Kurz K; Keck F; Staritz P; Lehrke S; Katus HA; Giannitsis E
    Thromb Haemost; 2008 Oct; 100(4):648-54. PubMed ID: 18841288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.